nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Affordability of antimicrobials for animals and humans in Vietnam: A call to revise pricing policies
|
Carrique-Mas, Juan |
|
2019 |
54 |
2 |
p. 269-270 |
artikel |
2 |
Antimicrobial activity of two novel antimicrobial peptides AA139 and SET-M33 against clinically and genotypically diverse Klebsiella pneumoniae isolates with differing antibiotic resistance profiles
|
van der Weide, Hessel |
|
2019 |
54 |
2 |
p. 159-166 |
artikel |
3 |
Change in antimicrobial susceptibility and PCR ribotypes of Clostridioides difficile in a hospital over 5 years: Correlation analysis with antimicrobial consumption
|
Seo, Mi-Ran |
|
2019 |
54 |
2 |
p. 154-158 |
artikel |
4 |
Clinical cure with ceftriaxone versus ceftaroline or ceftobiprole in the treatment of staphylococcal pneumonia: a systematic review and meta-analysis
|
Eljaaly, Khalid |
|
2019 |
54 |
2 |
p. 149-153 |
artikel |
5 |
Comparison of methods to analyse susceptibility of German MDR/XDR Pseudomonas aeruginosa to ceftazidime/avibactam
|
Schaumburg, Frieder |
|
2019 |
54 |
2 |
p. 255-260 |
artikel |
6 |
Comparisons of whole-genome sequencing and phenotypic drug susceptibility testing for Mycobacterium tuberculosis causing MDR-TB and XDR-TB in Thailand
|
Faksri, Kiatichai |
|
2019 |
54 |
2 |
p. 109-116 |
artikel |
7 |
Corrigendum to ‘Population pharmacokinetics of continuous infusion of piperacillin in critically ill patients’ [International Journal of Antimicrobial Agents 51 (2018) 594–600]
|
Dhaese, Sofie A.M. |
|
2019 |
54 |
2 |
p. 271 |
artikel |
8 |
Discovery of anti-mucoviscous activity of rifampicin and its potential as a candidate antivirulence agent against hypervirulent Klebsiella pneumoniae
|
Namikawa, Hiroki |
|
2019 |
54 |
2 |
p. 167-175 |
artikel |
9 |
Duration of therapy recommended for bacteraemic illness varies widely amongst clinicians
|
Alwan, Mostafa |
|
2019 |
54 |
2 |
p. 184-188 |
artikel |
10 |
Efficacy and safety of long-term maraviroc use in a heterogeneous group of HIV-infected patients: A retrospective cohort study
|
Weehuizen, J.M. |
|
2019 |
54 |
2 |
p. 215-222 |
artikel |
11 |
Efficacy of oritavancin alone and in combination against vancomycin-susceptible and -resistant enterococci in an in-vivo Galleria mellonella survival model
|
Meyer, Kevin A. |
|
2019 |
54 |
2 |
p. 197-201 |
artikel |
12 |
Efflux pumps AcrAB and OqxAB contribute to nitrofurantoin resistance in an uropathogenic Klebsiella pneumoniae isolate
|
Xu, Qingqing |
|
2019 |
54 |
2 |
p. 223-227 |
artikel |
13 |
Escherichia coli ST410 among humans and the environment in Southeast Asia
|
Nadimpalli, Maya L. |
|
2019 |
54 |
2 |
p. 228-232 |
artikel |
14 |
Evaluation of the BD Phoenix automated system for determining antimicrobial susceptibility against carbapenem-resistant Enterobacteriaceae compared with broth microdilution
|
Haffler, Zachary J. |
|
2019 |
54 |
2 |
p. 249-254 |
artikel |
15 |
Factors associated with successful completion of outpatient parenteral antibiotic therapy (OPAT): A 10-year review from a large West London service
|
Hatcher, James |
|
2019 |
54 |
2 |
p. 207-214 |
artikel |
16 |
High-dose trimethoprim-sulfamethoxazole and clindamycin for Staphylococcus aureus endocarditis
|
Tissot-Dupont, Hervé |
|
2019 |
54 |
2 |
p. 143-148 |
artikel |
17 |
Hot topics on vertebral osteomyelitis from the International Society of Antimicrobial Chemotherapy
|
Saeed, Kordo |
|
2019 |
54 |
2 |
p. 125-133 |
artikel |
18 |
If extraordinary data are not first corroborated, we risk being led astray: Occam's razor does not support the existence of plasmid–prophage chimeras. Comment on ‘Effects of cryptic prophage regions in a plasmid carrying a carbapenemase gene on survival against antibiotic stress’
|
Jobling, Michael G. |
|
2019 |
54 |
2 |
p. 265-266 |
artikel |
19 |
In-vitro adsorption and sieving coefficient of ticarcillin-clavulanate during continuous haemofiltration
|
T.P. Wan, Winnie |
|
2019 |
54 |
2 |
p. 261-264 |
artikel |
20 |
Ivermectin: From theory to clinical application
|
Ashour, Dalia S. |
|
2019 |
54 |
2 |
p. 134-142 |
artikel |
21 |
Non-intravenous carbapenem-sparing antibiotics for definitive treatment of bacteraemia due to Enterobacteriaceae producing extended-spectrum β-lactamase (ESBL) or AmpC β-lactamase: A propensity score study
|
Meije, Yolanda |
|
2019 |
54 |
2 |
p. 189-196 |
artikel |
22 |
Outbreak of NDM-1+CTX-M-15+DHA-1-producing Klebsiella pneumoniae high-risk clone in Spain owing to an undetectable colonised patient from Pakistan
|
Hernández-García, Marta |
|
2019 |
54 |
2 |
p. 233-239 |
artikel |
23 |
Pandemic spread of bla KPC-2 among Klebsiella pneumoniae ST11 in China is associated with horizontal transfer mediated by IncFII-like plasmids
|
Fu, Pan |
|
2019 |
54 |
2 |
p. 117-124 |
artikel |
24 |
Pharmacokinetics of dolutegravir 100 mg once daily with rifampicin
|
Wang, Xinzhu |
|
2019 |
54 |
2 |
p. 202-206 |
artikel |
25 |
Prophages enhance resistance to antibiotic stress in a bla NDM-1-carrying bacterial host: authors’ reply
|
Kim, So Yeon |
|
2019 |
54 |
2 |
p. 267-268 |
artikel |
26 |
Short versus long duration antimicrobial treatment for community-onset bacteraemia: A propensity score matching study
|
Lee, Ching-Chi |
|
2019 |
54 |
2 |
p. 176-183 |
artikel |
27 |
Title Page and Editorial Board
|
|
|
2019 |
54 |
2 |
p. i |
artikel |
28 |
Treatment of bone and joint infections caused by Enterobacter cloacae with a fluoroquinolone–cotrimoxazole combination
|
Cisse, Hawa |
|
2019 |
54 |
2 |
p. 245-248 |
artikel |
29 |
Urinary piperacillin/tazobactam pharmacokinetics in vitro to determine the pharmacodynamic breakpoint for resistant Enterobacteriaceae
|
Gould, M. |
|
2019 |
54 |
2 |
p. 240-244 |
artikel |